Artelo Biosciences, Inc. (ARTL)
ARTL Stock Price Chart
Explore Artelo Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze ARTL price movements and trends.
ARTL Company Profile
Discover essential business fundamentals and corporate details for Artelo Biosciences, Inc. (ARTL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
21 Jun 2019
Employees
6.00
Website
https://www.artelobio.comCEO
Gregory D. Gorgas
Description
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
ARTL Financial Timeline
Browse a chronological timeline of Artelo Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 10 Nov 2025
Earnings released on 13 Aug 2025
EPS came in at -$5.61 falling short of the estimated -$0.82 by -584.15%.
Stock split effective on 13 Jun 2025
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 May 2025
EPS came in at -$4.32 falling short of the estimated -$0.13 by -3.22K%.
Earnings released on 3 Mar 2025
EPS came in at -$7.02 falling short of the estimated -$4.44 by -58.11%.
Earnings released on 12 Nov 2024
EPS came in at -$2.10 surpassing the estimated -$2.46 by +14.63%.
Earnings released on 13 Aug 2024
EPS came in at -$4.50 surpassing the estimated -$4.98 by +9.64%.
Earnings released on 13 May 2024
EPS came in at -$4.68 surpassing the estimated -$6.30 by +25.71%.
Earnings released on 25 Mar 2024
EPS came in at -$5.94 falling short of the estimated -$1.74 by -241.38%.
Earnings released on 13 Nov 2023
EPS came in at -$4.98 falling short of the estimated -$4.20 by -18.57%.
Earnings released on 10 Aug 2023
EPS came in at -$0.56 surpassing the estimated -$0.81 by +30.86%.
Earnings released on 31 Mar 2023
EPS came in at -$1.18 falling short of the estimated -$0.73 by -61.64%.
Earnings released on 27 Mar 2023
EPS came in at -$7.07 falling short of the estimated -$0.73 by -868.72%.
Earnings released on 8 Nov 2022
EPS came in at -$0.82 surpassing the estimated -$0.91 by +9.89%.
Stock split effective on 10 Aug 2022
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Aug 2022
EPS came in at -$0.90 falling short of the estimated -$0.85 by -5.88%.
Earnings released on 12 May 2022
EPS came in at -$0.75 surpassing the estimated -$1.27 by +40.94%.
Earnings released on 12 Jan 2022
EPS came in at -$7.19 falling short of the estimated -$5.40 by -33.15%.
Earnings released on 29 Nov 2021
EPS came in at -$6.30 surpassing the estimated -$8.99 by +29.92%.
Earnings released on 12 Jul 2021
EPS came in at -$8.99 falling short of the estimated -$0.09 by -9.89K%.
Earnings released on 13 Apr 2021
EPS came in at -$9.89 falling short of the estimated -$0.11 by -8.89K%.
Earnings released on 14 Jan 2021
EPS came in at -$12.59 falling short of the estimated -$0.10 by -12.49K%.
Earnings released on 4 Nov 2020
EPS came in at -$17.99 falling short of the estimated -$0.36 by -4.90K%.
ARTL Stock Performance
Access detailed ARTL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.